Lietuvos onkologų chemoterapeutų draugija - financials and debts
Company age: 25 y. 9 mo.
Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 112,281 | 165,959 | 78,541 | 109,512 |
| Profit before tax | - | - | - | - | 0 | 0 | 0 | 0 |
| Net profit | - | - | - | - | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | 23,705 | 10,382 | 2,401 | 2,400 | 2,600 | 2,400 | 2,400 | 484 |
| Non-current assets | 4,518 | 3,912 | 5,079 | 305 | 0 | 0 | 0 | 0 |
| Current assets | 209,069 | 216,132 | 308,667 | 283,196 | 238,412 | 214,511 | 243,274 | 247,036 |
| Total assets | 213,587 | 220,044 | 313,746 | 283,501 | 238,412 | 214,511 | 243,274 | 247,036 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,076 | 436 | - |
| Social insurance contributions | - | - | - | - | - | 367 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +47.8% | -52.7% | +39.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
The company's overdue VMI debt amount as of 2026-09-25 is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-03-20 | 2026-09-25 | 0.16 |
| 2024-02-07 | 2026-03-08 | 0.16 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lietuvos onkologu chemoterapeutu draugija (code 195727627) is an Association engaged in activities of professional membership organisations. In the latest financial year, 2025, the organisation generated revenue of €109.5K, compared with €78.5K in 2024 and €166.0K in 2023. This points to a partial recovery in 2025 after a weaker 2024, while revenue remained below the 2023 level. The year-on-year revenue growth for 2025 was +39.4%, and the two-year change versus 2023 was -34.0%. Total assets increased gradually from €214.5K in 2023 to €243.3K in 2024 and €247.0K in 2025, indicating a stable asset base. Liabilities were low throughout the period, at €2.4K in 2023 and 2024, and €484 in 2025. The asset turnover ratio for 2025 was 0.44x, showing that the organisation generated a moderate level of revenue relative to its asset base.